Civic Intelligence

CLL Global Research Foundation Co Michael Keating

990 • Fiscal year 2023 • EIN 88-0517430

Jan 01, 2023 to Dec 31, 2023 • Filed on Apr 09, 2024

Organization Profilewww.cllglobal.org
1515 Holcombe Blvd Unit 428Houston, TX 77030

(713) 745-2376

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

56th percentile

0.24x

Higher debt load relative to assets than 56% of similar nonprofits.

2023 filings • 501(c)3 • $10M-$25M nonprofits • Source year 2023

Liabilities / Revenue

81st percentile

1.13x

Higher debt load relative to revenue than 81% of similar nonprofits.

2023 filings • 501(c)3 • $10M-$25M nonprofits • Source year 2023

Net Margin

12th percentile

-23%

Higher net margin than 12% of similar nonprofits.

2023 filings • 501(c)3 • $10M-$25M nonprofits • Source year 2023

Top Officer Pay

37th percentile

$145,850

Higher top officer pay than 37% of similar nonprofits.

Top officer pay equals 5.8% of source-year revenue.

2023 filings • 501(c)3 • $10M-$25M nonprofits • Source year 2023

Asset Growth

61st percentile

9.9%

Faster asset growth than 61% of similar nonprofits.

2023 filings • 501(c)3 • $10M-$25M nonprofits • Annualized from 2022 to 2023

Revenue Growth

87th percentile

47%

Faster revenue growth than 87% of similar nonprofits.

2023 filings • 501(c)3 • $10M-$25M nonprofits • Annualized from 2022 to 2023

Balance Sheet
Liabilities / Assets56th percentile

Assets

Up

$12,019,246

Up $1,080,474 (+9.9%) from 2022

Net Assets

Up

$9,142,388

Up $292,332 (+3.3%) from 2022

Liabilities

Up

$2,876,858

Up $788,142 (+38%) from 2022

Revenue And Expenses
Liabilities / Revenue81st percentileNet Margin12th percentile

Revenue

Up

$2,535,609

Up $816,158 (+47%) from 2022

Expenses

Up

$3,129,589

Up $992,865 (+46%) from 2022

Net Income

Down

-$593,980

Down $176,707 (-42%) from 2022

Historical Trend

Balance Sheet Trend

Asset Growth61st percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$15M$10M$5.0M$0Assets 2010: $8,782,166Liabilities 2010: $628,257Net Assets 2010: $8,153,9092010Assets 2011: $8,020,254Liabilities 2011: $998,811Net Assets 2011: $7,021,4432011Assets 2012: $9,075,945Liabilities 2012: $962,759Net Assets 2012: $8,113,1862012Assets 2013: $8,338,745Liabilities 2013: $1,347,991Net Assets 2013: $6,990,7542013Assets 2014: $9,337,548Liabilities 2014: $928,685Net Assets 2014: $8,408,8632014Assets 2015: $9,655,956Liabilities 2015: $1,135,717Net Assets 2015: $8,520,2392015Assets 2016: $9,879,593Liabilities 2016: $773,731Net Assets 2016: $9,105,8622016Assets 2017: $10,086,166Liabilities 2017: $779,069Net Assets 2017: $9,307,0972017Assets 2018: $10,751,605Liabilities 2018: $942,444Net Assets 2018: $9,809,1612018Assets 2019: $11,232,544Liabilities 2019: $1,209,393Net Assets 2019: $10,023,1512019Assets 2020: $11,845,226Liabilities 2020: $1,360,372Net Assets 2020: $10,484,8542020Assets 2021: $12,430,009Liabilities 2021: $2,039,821Net Assets 2021: $10,390,1882021Assets 2022: $10,938,772Liabilities 2022: $2,088,716Net Assets 2022: $8,850,0562022Assets 2023: $12,019,246Liabilities 2023: $2,876,858Net Assets 2023: $9,142,3882023Assets 2024: $11,594,434Liabilities 2024: $2,181,290Net Assets 2024: $9,413,1442024

Highlighted filing

2023

Assets$12,019,246
Liabilities$2,876,858
Net Assets$9,142,388
Open 2023 Filing

Operations Trend

Revenue Growth87th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$4.0M$2.0M$0-$2.0MExpenses 2010: $1,173,9942010Expenses 2011: $3,209,0482011Expenses 2012: $1,476,2902012Revenue 2013: $2,167,481Expenses 2013: $3,248,524Net Income 2013: -$1,081,0432013Revenue 2014: $1,837,893Expenses 2014: $385,781Net Income 2014: $1,452,1122014Revenue 2015: $2,184,044Expenses 2015: $1,981,687Net Income 2015: $202,3572015Revenue 2016: $2,242,471Expenses 2016: $1,722,046Net Income 2016: $520,4252016Revenue 2017: $2,017,911Expenses 2017: $1,800,258Net Income 2017: $217,6532017Revenue 2018: $2,953,861Expenses 2018: $2,184,123Net Income 2018: $769,7382018Revenue 2019: $1,825,114Expenses 2019: $1,980,059Net Income 2019: -$154,9452019Revenue 2020: $2,331,974Expenses 2020: $2,430,026Net Income 2020: -$98,0522020Revenue 2021: $2,747,960Expenses 2021: $3,008,640Net Income 2021: -$260,6802021Revenue 2022: $1,719,451Expenses 2022: $2,136,724Net Income 2022: -$417,2732022Revenue 2023: $2,535,609Expenses 2023: $3,129,589Net Income 2023: -$593,9802023Revenue 2024: $3,057,835Expenses 2024: $3,450,542Net Income 2024: -$392,7072024

Highlighted filing

2023

Revenue$2,535,609
Expenses$3,129,589
Net Income-$593,980
Open 2023 Filing
Jump To
Filing Snapshot
Filing Period
Jan 1, 2023 to Dec 31, 2023
Signed
Apr 9, 2024
Return Version
2023v5.0
Gross Receipts
$24,880,681
Mission and Program Overview

Mission

Our mission is to abolish chronic lymphocytic leukemia (CLL) as a threat to the life and health of patients by accelerating CLL research.

To accelerate progress toward the control and cure of chronic lymphocytic leukemia (CLL).

Balance Sheet Detail
LineBeginningEndChange
Assets
Investments in Publicly Traded Securities$6,858,283$8,570,549▲ $1,712,266
Cash and Non-Interest-Bearing Accounts$1,699,949$2,540,044▲ $840,095
Pledges and Grants Receivable$659,721$504,594▼ $155,127
Savings and Temporary Cash Investments$1,719,119$399,559▼ $1,319,560
Prepaid Expenses and Deferred Charges$1,700$4,500▲ $2,800
Total Assets$10,938,772$12,019,246▲ $1,080,474
Liabilities
Grants Payable$2,067,930$2,842,006▲ $774,076
Accounts Payable and Accrued Expenses$20,786$34,852▲ $14,066
Total Liabilities$2,088,716$2,876,858▲ $788,142
Net Assets / Fund Balance
Net Assets Without Donor Restrictions$8,190,335$8,637,794▲ $447,459
Net Assets With Donor Restrictions$659,721$504,594▼ $155,127
Total Net Assets Fund Balance$8,850,056$9,142,388▲ $292,332
Total Liabilities and Net Assets / Fund Balance$10,938,772$12,019,246▲ $1,080,474
Compensation and Service Providers
Top Officer Pay37th percentile

Employees

NameTitleFull / Part TimeBaseTotal
Sam Margaret PaceCDOFT$145,850$145,850
William WierdaPresident & CEO-$14,531$14,531

Board Members and Trustees

NameTitle
Diane Lee KraitmanDirector
Louis KatopodisDirector
Martin RaberDirector
Phyllis CohenDirector
Richard EvansDirector
Richard MarschnerDirector
Robert NicholsDirector
Steve WinfieldDirector
William PlunkettDirector
Michael J KeatingFounding Director
Revenue and Support

Revenue Composition

Contributions and Grants
$2,469,879
Program Service Revenue
$0
Investment Income
$65,730
Other Revenue
$0
All Other Contributions
$2,469,879
Change in Net Assets
$-593,980

Audited Revenue Reconciliation

Revenue per Audited Statements
$2,522,460
Revenue Not Reported on Financial Statements
$13,149
Revenue Not Reported on Form 990
$986,693
Total Revenue per Audited Statements
$3,509,153
Total Revenue per Form 990
$2,535,609
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Grants and Similar Amounts Paid$2,832,011
Other Expenses$217,578
Salaries, Compensation, and Employee Benefits$80,000
Total Fundraising Expense$42,858
Professional Fundraising Fees$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Grants to Domestic Orgs$2,732,011--$2,732,011
Foreign Grants$100,000--$100,000
Conferences and Meetings$45,704$17,722-$63,426
Current Officers, Directors, Trustees, and Key Employees$38,400$10,800$10,800$60,000
Travel$56,006--$56,006
Information Technology$13,239$7,488$18,766$39,493
Other Salaries and Wages$17,600$1,200$1,200$20,000
Fees for Services Accounting-$19,532-$19,532
Office Expenses$733$10,131$4,837$15,701
Fees for Service Investment Mgmnt Fees-$13,149-$13,149
Fees for Services Other--$7,255$7,255
Insurance-$3,016-$3,016
Total Functional Expenses$3,003,693$83,038$42,858$3,129,589

Audited Expense Reconciliation

Line ItemAmount
Total Expenses per Audited Statements$3,216,821
Total Expenses per Form 990$3,129,589
Expenses per Audited Statements$3,116,440
Expenses Not Reported on Form 990$100,381
Expenses Not Reported on Financial Statements$13,149
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
UT MD Anderson Cancer CenterHouston, TXGovt.CLL research grant$2,267,011
Ohio State UniversityColumbus, OHGovt.CLL research grant$350,000
Feinstein Institute for Medical ResearchWestbury, NY501(c)(3)CLL research grant$115,000

International Summary

Offices
0
Employees
0
Spending
$100,000

International Compliance

Foreign grant records maintained
Yes
Activity in boycott countries
No
Foreign corporation ownership
No
Foreign partnership interest
No
Interest in foreign trust
No
Passive foreign investment company interest
No
Transfers to foreign corporations
No

International Activities

RegionActivityServicesOfficesEmployeesSpending
Middle East and North AfricaGrantmaking-00$100,000
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Insider Transactions and Loans

Interested-Person Transactions

Interested PartyRelationshipDescriptionShared RevenueAmount
-Officer's sonIT servicesNo$21,022
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Backup withholding compliance
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
Yes
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
Yes
CEO compensation reviewed
Yes
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section B, line 11B

“A draft of Form 990 is sent to the board of directors in advance of the April/May board meeting. The board reviews Form 990 prior to and during the meeting. A formal motion is considered to approve and submit Form 990 to the IRS.”

Form 990, Part VI, Section B, line 12C

“Each board member is required to make an annual disclosure of any conflicts of interest. A board meeting is then held to review any disclosed conflicts.”

Form 990, Part VI, Section B, line 15A

“The top officials are employed and compensated by the University of Texas MD Anderson Cancer Center. See Schedule J and Schedule O.”

Form 990, Part VI, Section C, line 19

“These documents are provided upon request.”

Part VII Compensation Explanation - William Wierda

“Dr. William Wierda is employed by the University of Texas MD Anderson Cancer Center. MD Anderson allows him time as needed to perform his assigned functions for CLL Global. In 2023, an estimated amount of $14,531 of the compensation he received from MD Anderson is attributed to his services performed for CLL Global. MD Anderson donates the cost of providing these services to CLL Global. This amount has been reported on Part VII, column (d).”

Part VII Compensation Explanation - Sam (Margaret) Pace

“Sam (Margaret) Pace is employed by the University of Texas MD Anderson Cancer Center. MD Anderson allows her time as needed to perform her assigned functions for CLL Global. In 2023, an estimated amount of $85,850 of the compensation she received from MD Anderson is attributed to her services performed for CLL Global. MD Anderson donates the cost of providing these services to CLL Global. This amount has been reported on Part VII, column (d), in addition to $60,000 of compensation paid directly by CLL Global.”

Filing and Contact Details

Filer

Filer Name
CLL Global Research Foundation
EIN
88-0517430
Phone
7137452376
Address
1515 Holcombe Blvd Unit 428, Houston, TX 77030

Signing Officer

Name
Dr William Wierda
Title
President & CEO
Phone
7137452376
Signed
2024-04-09
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Dr William Wierda
Formed
2003
Legal Domicile
TX
Voting Board Members
11
Independent Board Members
10
Employees
0
Volunteers
10

Preparer

Firm
Blazek & Vetterling
Address
2900 Weslayan Suite 200, Houston, TX 77027
Preparer
Barbara Murphy
Phone
7134395739
Raw XML AppendixShowing 400 of 553 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt020786
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt034852
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0To accelerate progress toward the control and cure of chronic lymphocytic leukemia (CLL).
IRS990/AllOtherContributionsAmt02469879
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd01
IRS990/BackupWthldComplianceInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0William Wierda
IRS990/BooksInCareOfDetail/PhoneNum07137452376
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt01515 Holcombe Unit 428
IRS990/BooksInCareOfDetail/USAddress/CityNm0Houston
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0TX
IRS990/BooksInCareOfDetail/USAddress/ZIPCd077030
IRS990/BusinessRlnWith35CtrlEntInd00
IRS990/BusinessRlnWithFamMemInd01
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CashNonInterestBearingGrp/BOYAmt01699949
IRS990/CashNonInterestBearingGrp/EOYAmt02540044
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd00
IRS990/CompCurrentOfcrDirectorsGrp/FundraisingAmt010800
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt010800
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt038400
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt060000
IRS990/CompensationFromOtherSrcsInd01
IRS990/CompensationProcessCEOInd01
IRS990/CompensationProcessOtherInd00
IRS990/ConferencesMeetingsGrp/ManagementAndGeneralAmt017722
IRS990/ConferencesMeetingsGrp/ProgramServicesAmt045704
IRS990/ConferencesMeetingsGrp/TotalAmt063426
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd00
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt02469879
IRS990/CYGrantsAndSimilarPaidAmt02832011
IRS990/CYInvestmentIncomeAmt065730
IRS990/CYOtherExpensesAmt0217578
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt0-593980
IRS990/CYSalariesCompEmpBnftPaidAmt080000
IRS990/CYTotalExpensesAmt03129589
IRS990/CYTotalFundraisingExpenseAmt042858
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt02535609
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DelegationOfMgmtDutiesInd00
IRS990/Desc0RESEARCH GRANTS: The CLL Global Research Foundation's primary activity is to accelerate research. The need is urgent to accelerate promising, untapped areas of research. CLL Global provides grants through several mechanisms to fund novel, patient-oriented concepts. The intention is to fund the best CLL science in the world. In particular, CLL Global targets monoclonal antibodies, prognostic factors, vaccines & gene therapy, CLL survival pathway, genetics, molecular targets, and drug development. Continued on Schedule O A Scientific Advisory Board (SAB) develops the research priorities and oversees the development and implementation of the submission, evaluation and funding process for grant application cycles. SAB members have extensive experience in treating CLL patients, developing new drugs and other tools, and studying various aspects of the disease. The research grant section also allows support of postdoctoral fellows conducting a CLL-specific project. In 2023, CLL Global awarded new research/individual grants ranging from $100,000-$250,000. Applicants initially submit proposals for up to $110,000 in funding for one year. Applicants identify project milestones. Upon demonstration of sufficient progress, investigators will be considered for a second year of funding. For accounting purposes, CLL Global expenses grants at the time of completion of a sponsored research agreement.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DonorAdvisedFundInd00
IRS990/DonorRestrictionNetAssetsGrp/BOYAmt0659721
IRS990/DonorRestrictionNetAssetsGrp/EOYAmt0504594
IRS990/DonorRstrOrQuasiEndowmentsInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt00
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt02832011
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt019532
IRS990/FeesForServicesAccountingGrp/TotalAmt019532
IRS990/FeesForServicesOtherGrp/FundraisingAmt07255
IRS990/FeesForServicesOtherGrp/TotalAmt07255
IRS990/FeesForSrvcInvstMgmntFeesGrp/ManagementAndGeneralAmt013149
IRS990/FeesForSrvcInvstMgmntFeesGrp/TotalAmt013149
IRS990/ForeignActivitiesInd01
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignGrantsGrp/ProgramServicesAmt0100000
IRS990/ForeignGrantsGrp/TotalAmt0100000
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt02.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt14.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt31.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt41.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt51.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt61.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt71.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt81.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt91.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt101.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1135.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd7X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd8X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd9X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd10X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt70
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt80
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt90
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt100
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt110
IRS990/Form990PartVIISectionAGrp/PersonNm0Michael J Keating
IRS990/Form990PartVIISectionAGrp/PersonNm1William Wierda
IRS990/Form990PartVIISectionAGrp/PersonNm2Phyllis Cohen
IRS990/Form990PartVIISectionAGrp/PersonNm3Richard Evans
IRS990/Form990PartVIISectionAGrp/PersonNm4Louis Katopodis
IRS990/Form990PartVIISectionAGrp/PersonNm5Diane Lee Kraitman
IRS990/Form990PartVIISectionAGrp/PersonNm6Richard Marschner
IRS990/Form990PartVIISectionAGrp/PersonNm7Robert Nichols
IRS990/Form990PartVIISectionAGrp/PersonNm8William Plunkett
IRS990/Form990PartVIISectionAGrp/PersonNm9Martin Raber
IRS990/Form990PartVIISectionAGrp/PersonNm10Steve Winfield
IRS990/Form990PartVIISectionAGrp/PersonNm11Sam Margaret Pace
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt114531
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt11145850
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt110
IRS990/Form990PartVIISectionAGrp/TitleTxt0Founding Director
IRS990/Form990PartVIISectionAGrp/TitleTxt1President & CEO
IRS990/Form990PartVIISectionAGrp/TitleTxt2Director
IRS990/Form990PartVIISectionAGrp/TitleTxt3Director
IRS990/Form990PartVIISectionAGrp/TitleTxt4Director
IRS990/Form990PartVIISectionAGrp/TitleTxt5Director
IRS990/Form990PartVIISectionAGrp/TitleTxt6Director
IRS990/Form990PartVIISectionAGrp/TitleTxt7Director
IRS990/Form990PartVIISectionAGrp/TitleTxt8Director
IRS990/Form990PartVIISectionAGrp/TitleTxt9Director
IRS990/Form990PartVIISectionAGrp/TitleTxt10Director
IRS990/Form990PartVIISectionAGrp/TitleTxt11CDO
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr02003
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedBasisGrp/SeparateBasisFinclStmtInd0X
IRS990/FSAuditedInd01
IRS990/FundraisingActivitiesInd00
IRS990/GainOrLossGrp/SecuritiesAmt0-231266
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt011
IRS990/GrantAmt02832011
IRS990/GrantsPayableGrp/BOYAmt02067930
IRS990/GrantsPayableGrp/EOYAmt02842006
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt02732011
IRS990/GrantsToDomesticOrgsGrp/TotalAmt02732011
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd01
IRS990/GrantToRelatedPersonInd00
IRS990/GrossAmountSalesAssetsGrp/SecuritiesAmt022113806
IRS990/GrossReceiptsAmt024880681
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd00
IRS990/IndependentAuditFinclStmtInd01
IRS990/IndependentVotingMemberCnt010
IRS990/IndivRcvdGreaterThan100KCnt01
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InformationTechnologyGrp/FundraisingAmt018766
IRS990/InformationTechnologyGrp/ManagementAndGeneralAmt07488
IRS990/InformationTechnologyGrp/ProgramServicesAmt013239
IRS990/InformationTechnologyGrp/TotalAmt039493
IRS990/InsuranceGrp/ManagementAndGeneralAmt03016
IRS990/InsuranceGrp/TotalAmt03016
IRS990/InvestmentIncomeGrp/ExclusionAmt0296996
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt0296996
IRS990/InvestmentInJointVentureInd00
IRS990/InvestmentsPubTradedSecGrp/BOYAmt06858283
IRS990/InvestmentsPubTradedSecGrp/EOYAmt08570549
IRS990/IRPDocumentCnt07
IRS990/IRPDocumentW2GCnt00
IRS990/LegalDomicileStateCd0TX
IRS990/LessCostOthBasisSalesExpnssGrp/SecuritiesAmt022345072
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd00
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0CLL Global's mission is to abolish chronic lymphocytic leukemia (CLL) as a threat to the life and health of patients by accelerating CLL research.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd01
IRS990/NetAssetsOrFundBalancesBOYAmt08850056
IRS990/NetAssetsOrFundBalancesEOYAmt09142388
IRS990/NetGainOrLossInvestmentsGrp/ExclusionAmt0-231266
IRS990/NetGainOrLossInvestmentsGrp/TotalRevenueColumnAmt0-231266
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NetUnrlzdGainsLossesInvstAmt0886312
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt08190335
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt08637794
IRS990/NondeductibleContributionsInd00
IRS990/OfficeExpensesGrp/FundraisingAmt04837
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt010131
IRS990/OfficeExpensesGrp/ProgramServicesAmt0733
IRS990/OfficeExpensesGrp/TotalAmt015701
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherChangesInNetAssetsAmt00
IRS990/OtherSalariesAndWagesGrp/FundraisingAmt01200
IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt01200
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt017600
IRS990/OtherSalariesAndWagesGrp/TotalAmt020000
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PledgesAndGrantsReceivableGrp/BOYAmt0659721
IRS990/PledgesAndGrantsReceivableGrp/EOYAmt0504594
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt01700
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt04500
IRS990/PrincipalOfficerNm0Dr William Wierda
IRS990/ProfessionalFundraisingInd00
IRS990/ProgSrvcAccomActy2Grp/Desc0ALLIANCE: The US/European Alliance for the Therapy of CLL (Alliance) is comprised of 25 individuals from the United States and Europe, representing the world's experts in CLL research. The members are divided into working groups focusing on one of five big ideas in CLL research (new drugs, gene/vaccine therapy, genetics, CLL-stromal interactions, transplant/immune reconstitution). The Alliance was built to encourage close collaboration within and among working groups. As such, meetings are held to bring investigators together to collaborate.
IRS990/ProgSrvcAccomActy2Grp/ExpenseAmt0146498
IRS990/ProgSrvcAccomActy3Grp/Desc0EDUCATION: CLL Global Research Foundation hosts annual interactive patient education events where CLL patients learn about emerging therapies, current treatment options and support resources from leading CLL experts. Both virtual and in-person events were held in 2023.
IRS990/ProgSrvcAccomActy3Grp/ExpenseAmt025184
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt02693348
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt01903748
IRS990/PYInvestmentIncomeAmt0-973897
IRS990/PYOtherExpensesAmt0162976
IRS990/PYOtherRevenueAmt00
IRS990/PYProgramServiceRevenueAmt00
IRS990/PYRevenuesLessExpensesAmt0-417273
IRS990/PYSalariesCompEmpBnftPaidAmt070000
IRS990/PYTotalExpensesAmt02136724
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt01719451
IRS990/QuidProQuoContributionsInd00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt0-593980
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd00
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd00
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd00
IRS990/ReportProgramRelatedInvstInd00
IRS990/SavingsAndTempCashInvstGrp/BOYAmt01719119
IRS990/SavingsAndTempCashInvstGrp/EOYAmt0399559
IRS990ScheduleA/FactsAndCircumstancesTestTxt0Based on the information set forth below, CLL Global Research Foundation believes it qualifies as a publicly supported charity described in IRC 509(a)(1) pursuant to the facts and circumstances test found in Treasury Regulation 1.170A-9(e)(3). Percentage of Financial Support: CLL Global Research Foundation's public support percentage stands at 28.71% for the 2023 calendar year.Active Fundraising Efforts: The organization's ongoing research grants have been made possible by large donations from a significant donor. Over the last few years, this donor has increased their annual support of the Foundation. CLL Global Research Foundation has conducted a continuous and bona fide fundraising program designed to attract new and additional public and governmental support. In the past two years, CLL Global Research Foundation has invested more staff and financial resources in its development program in order to expand and diversify its funding base. Representative Governing Body: CLL Global Research Foundation's board of directors is comprised of 11 members representing expertise in medical research and community enterprises, all of whom are passionate about funding CLL research and treatment options. Sources of Support: CLL Global Research Foundation receives grants from an ever-expanding donor base including individuals, foundations, companies and governmental agencies. The Foundation is currently making improvements to its development strategy in order to attract new and additional public support. Program Availability and General Public Participation: CLL Global Research Foundation seeks to make grants to various medical institutions who are at the forefront of conducting CLL research, both in the United States and worldwide.
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt02469879
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt02693348
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt02155908
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt02082621
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt01774190
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt011175946
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/CurrentTaxYearAmt0100381
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/CurrentTaxYearMinus1YearAmt098489
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/CurrentTaxYearMinus2YearsAmt097840
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/CurrentTaxYearMinus3YearsAmt097839
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/CurrentTaxYearMinus4YearsAmt095276
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/TotalAmt0489825
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt0296996
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt0131862
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt0226764
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt0168679
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt0150924
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt0975225
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.28710
IRS990ScheduleA/PublicSupportPY170Pct00.31380
IRS990ScheduleA/PublicSupportTotal170Amt03628840
IRS990ScheduleA/SubstantialContributorsTotAmt08036931
IRS990ScheduleA/TenPctFactsCrcmstncsTestCYInd0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt02570260
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt02791837
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt02253748
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt02180460
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt01869466
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt011665771
IRS990ScheduleA/TotalSupportAmt012640996
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd01
IRS990ScheduleD/DonatedServicesAndUseFcltsAmt0100381
IRS990ScheduleD/DonatedServicesUseFcltsAmt0100381
IRS990ScheduleD/ExpensesNotReportedAmt0100381
IRS990ScheduleD/ExpensesNotRptFinclStmtAmt013149
IRS990ScheduleD/ExpensesSubtotalAmt03116440
IRS990ScheduleD/InvestmentExpensesNotIncld2Amt013149
IRS990ScheduleD/InvestmentExpensesNotIncldAmt013149
IRS990ScheduleD/NetUnrealizedGainsInvstAmt0886312
IRS990ScheduleD/RevenueNotReportedAmt0986693
IRS990ScheduleD/RevenueNotReportedFinclStmtAmt013149
IRS990ScheduleD/RevenueSubtotalAmt02522460
IRS990ScheduleD/TotalBookValueLandBuildingsAmt00
IRS990ScheduleD/TotalExpensesPerForm990Amt03129589
IRS990ScheduleD/TotalRevenuePerForm990Amt02535609
IRS990ScheduleD/TotalRevEtcAuditedFinclStmtAmt03509153
IRS990ScheduleD/TotExpnsEtcAuditedFinclStmtAmt03216821
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt00
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt00
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt0100000
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt0Middle East and North Africa
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt0Grantmaking
IRS990ScheduleF/BoycottCountriesInd00
IRS990ScheduleF/ContinuationSpentAmt00
IRS990ScheduleF/ContinuationTotalEmployeeCnt00
IRS990ScheduleF/ContinuationTotalOfficeCnt00
IRS990ScheduleF/ForeignCorpOwnershipInd00
IRS990ScheduleF/ForeignPartnershipInd00
IRS990ScheduleF/GrantRecordsMaintainedInd01
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt0100000
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/MannerOfCashDisbursementTxt0EFT
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/NonCashAssistanceAmt00
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/PurposeOfGrantTxt0CLL research
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/RegionTxt0Middle East and North Africa
IRS990ScheduleF/InterestInForeignTrustInd00
IRS990ScheduleF/PassiveForeignInvestmestCoInd00
IRS990ScheduleF/SubtotalEmployeesCnt00
IRS990ScheduleF/SubtotalOfficesCnt00
IRS990ScheduleF/SubtotalSpentAmt0100000
IRS990ScheduleF/SupplementalInformationDetail/ExplanationTxt0After a grant is awarded, members of the Scientific Advisory Board (SAB) review annual progress reports to determine whether an additional year of funding is warranted. If additional funds are awarded, grant recipients must provide additional progress reports to the SAB.
IRS990ScheduleF/SupplementalInformationDetail/ExplanationTxt1Part I, column (f) amounts are reported on the accrual method of accounting.
IRS990ScheduleF/SupplementalInformationDetail/FormAndLineReferenceDesc0Part I, Line 2:
IRS990ScheduleF/SupplementalInformationDetail/FormAndLineReferenceDesc1Part I, line 3:
IRS990ScheduleF/Total501c3OrgCnt01
IRS990ScheduleF/TotalEmployeeCnt00
IRS990ScheduleF/TotalOfficeCnt00
IRS990ScheduleF/TotalSpentAmt0100000
IRS990ScheduleF/TransferToForeignCorpInd00
IRS990ScheduleI/GrantRecordsMaintainedInd01
IRS990ScheduleI/RecipientTable/CashGrantAmt02267011
IRS990ScheduleI/RecipientTable/CashGrantAmt1115000
IRS990ScheduleI/RecipientTable/CashGrantAmt2350000
IRS990ScheduleI/RecipientTable/IRCSectionDesc0Govt.
IRS990ScheduleI/RecipientTable/IRCSectionDesc1501(c)(3)
IRS990ScheduleI/RecipientTable/IRCSectionDesc2Govt.
IRS990ScheduleI/RecipientTable/NonCashAssistanceAmt00
IRS990ScheduleI/RecipientTable/NonCashAssistanceAmt10
IRS990ScheduleI/RecipientTable/NonCashAssistanceAmt20
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt0CLL research grant
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt1CLL research grant
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt2CLL research grant
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt0UT MD Anderson Cancer Center
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt1Feinstein Institute for Medical Research
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt2Ohio State University
IRS990ScheduleI/RecipientTable/RecipientEIN0746001118
IRS990ScheduleI/RecipientTable/RecipientEIN1112673595
IRS990ScheduleI/RecipientTable/RecipientEIN2316025986
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt0PO Box 4486
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt1972 Brush Hollow Rd 5th Fl
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt2281 W Lane Ave
IRS990ScheduleI/RecipientTable/USAddress/CityNm0Houston
IRS990ScheduleI/RecipientTable/USAddress/CityNm1Westbury
IRS990ScheduleI/RecipientTable/USAddress/CityNm2Columbus
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd0TX
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd1NY
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd2OH
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd077210
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd111590

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2023 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$12,019,246
Liabilities
$2,876,858
Net assets
$9,142,388
Revenue
$2,535,609
Expenses
$3,129,589
Net income
-$593,980
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$11.6$2.18$9.41$3.06$3.45$0.39
2023Detailed filing. Detailed filing data is available for this year.$12.0$2.88$9.14$2.54$3.13$0.59
2022Detailed filing. Detailed filing data is available for this year.$10.9$2.09$8.85$1.72$2.14$0.42
2021Detailed filing. Detailed filing data is available for this year.$12.4$2.04$10.4$2.75$3.01$0.26
2020XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$11.8$1.36$10.5$2.33$2.43$0.10
2019Detailed filing. Detailed filing data is available for this year.$11.2$1.21$10.0$1.83$1.98$0.15
2018Detailed filing. Detailed filing data is available for this year.$10.8$0.94$9.81$2.95$2.18$0.77
2017Detailed filing. Detailed filing data is available for this year.$10.1$0.78$9.31$2.02$1.80$0.22
2016Detailed filing. Detailed filing data is available for this year.$9.88$0.77$9.11$2.24$1.72$0.52
2015Detailed filing. Detailed filing data is available for this year.$9.66$1.14$8.52$2.18$1.98$0.20
2014XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$9.34$0.93$8.41$1.84$0.39$1.45
2013Detailed filing. Detailed filing data is available for this year.$8.34$1.35$6.99$2.17$3.25$1.08
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$9.08$0.96$8.11$1.48
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$8.02$1.00$7.02$3.21
2010Facts available. Structured filing facts are available, but richer extracted sections are limited.$8.78$0.63$8.15$1.17